Absorption, Bioavailability, and Immunogenicity after Subcutaneous Administration: Evaluation of a Subcutaneous Platform within the Open Systems Pharmacology framework PAGE 32 (2024) Abstr 11022 Pellowe M, Selvaggio G, Benamara S, Dubbelboer I, Teutonico D, Chenel M, Sjögren E. ConferencePBPK/PBBMProgram strategies and efficienciesQSP Pharmetheus Affiliates Director, MIDD Consultant Moriah Pellowe See bio Director, MIDD Consultant Gianluca Selvaggio See bio Chief Research Officer Marylore Chenel See bio Principal Director, PBPK & PBBM Scientific Lead Erik Sjögren See bio
